Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,024B 10.64B 9.3B 8.58B 7.89B 14.95B 15.21B 102B 40.21B 501B 39.97B 39.09B 1,725B P/E 2027 *
24.4x
P/E 2028 * 19.5x
Enterprise Value 991B 10.3B 9.01B 8.31B 7.64B 14.47B 14.72B 99.21B 38.93B 485B 38.69B 37.85B 1,670B EV / Sales 2027 *
2.79x
EV / Sales 2028 * 2.46x
Free-Float
70.07%
Yield 2027 *
0.63%
Yield 2028 * 0.68%

Last Transcript: Dr. Reddy's Laboratories Limited

1 day-1.28%
1 week-9.16%
Current month-9.36%
1 month-3.46%
3 months-0.44%
6 months+3.65%
Current year-3.25%
1 week 1,222
Extreme 1222
1,348.75
1 month 1,222
Extreme 1222
1,414.4
Current year 1,149
Extreme 1149
1,414.4
1 year 1,149
Extreme 1149
1,414.4
3 years 1,018.4
Extreme 1018.4
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 12/05/2014
Chairman 65 01/04/2013
Director/Board Member 65 24/10/2018
Date Insider Type Main position Quantity % Market Cap.
03-31Other

Global Head of Quality and PV

35,600 0.0043%
12-17Other

CEO - Global Generics

68,230 0.0082%
12-17Other

Chief Financial Officer

61,245 0.0073%
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-9.16%-1.69%+20.80% 10.8B
+0.23%-4.96%+49.73%+158.42% 1,028B
-2.01%-5.69%+60.09%+56.16% 611B
+0.71%-2.42%+32.32%+82.92% 432B
+0.98%-1.40%+29.49%+23.12% 323B
-0.34%-3.10%+27.00%+43.66% 277B
+1.63%-11.76%+19.72%+23.20% 257B
+3.39%+2.29%-23.68%-38.33% 217B
+0.93%-2.56%+22.58%+57.37% 192B
+1.36%-2.96%+20.85%+70.11% 161B
Average +0.60%-5.51%+23.64%+49.74% 350.91B
Weighted average by Cap. +0.34%-5.52%+36.03%+77.73%

Financials

2027 *2028 *
Net sales 356B 3.7B 3.23B 2.98B 2.74B 5.2B 5.28B 35.61B 13.97B 174B 13.89B 13.59B 600B 395B 4.1B 3.59B 3.31B 3.04B 5.76B 5.86B 39.49B 15.49B 193B 15.4B 15.06B 665B
Net income 42.23B 439M 384M 354M 325M 617M 627M 4.23B 1.66B 20.64B 1.65B 1.61B 71.14B 53.11B 552M 483M 445M 409M 775M 789M 5.32B 2.09B 25.96B 2.07B 2.03B 89.48B
Net Debt -32.67B -340M -297M -274M -252M -477M -485M -3.27B -1.28B -15.97B -1.27B -1.25B -55.03B -54.24B -564M -493M -455M -418M -792M -805M -5.43B -2.13B -26.51B -2.12B -2.07B -91.38B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
15/07/26 1,229.80 -1.28% 69,828
14/07/26 ₹1,245.75 +0.90% 90,099
13/07/26 ₹1,234.60 -0.88% 141,261
10/07/26 ₹1,245.50 -1.91% 399,100
09/07/26 ₹1,269.80 -5.85% 330,028
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,229.80INR
Average target price
1,333.18INR
Spread / Average Target
+8.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock